Advertisement
Screener

Acorda Therapeutics, Inc. Financing Cash Flow

Acorda Therapeutics, Inc. Financing Cash Flow

Acorda Therapeutics, Inc. reported Financing Cash Flow of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2024-04-01

  • Acorda Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was $0.00.
  • Acorda Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-09-30 was $0.00.
  • Acorda Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-06-30 was -$69.00M.
  • Acorda Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-03-31 was -$655.00K.
  • Acorda Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $0.00.
  • Acorda Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $0.00.
  • Acorda Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2021 was -$69.66M.
  • Acorda Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2020 was -$1.67M.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 3 month as first filedNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 6 month as first filedNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 9 month as first filedNet Cash Provided by (Used in) Financing Activities 12 monthNet Cash Provided by (Used in) Financing Activities 12 month as first filed
2023-12-31$0.00
10-K · filed 2024-04-01
2022-12-31$0.00
10-K · filed 2024-04-01
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
$0.00
derived: sum of 2 quarters · filed 2023-03-15
-$69.00M
derived: sum of 3 quarters · filed 2023-03-15
-$69.66M
10-K · filed 2023-03-15
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$69.00M
derived: sum of 2 quarters · filed 2022-11-14
-$69.66M
10-Q · filed 2022-11-14
$4.31M
10-Q · filed 2021-11-12
-$69.66M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$69.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$69.66M
10-Q · filed 2022-08-09
$4.31M
10-Q · filed 2021-08-12
-$69.66M
derived: sum of 3 quarters · filed 2022-08-09
-$69.75M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31-$655.00K
10-Q · filed 2022-05-13
$73.31M
10-Q · filed 2021-05-12
-$655.00K
derived: sum of 2 quarters · filed 2022-05-13
-$745.00K
derived: sum of 3 quarters · filed 2022-05-13
-$745.00K
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18
-$90.00K
derived: sum of 2 quarters · filed 2022-03-18
-$90.00K
derived: sum of 3 quarters · filed 2022-03-18
-$1.67M
10-K · filed 2022-03-18
2020-09-30-$90.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$90.00K
derived: sum of 2 quarters · filed 2021-11-12
-$1.67M
10-Q · filed 2021-11-12
-$61.54M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$1.58M
10-Q · filed 2021-08-12
-$61.45M
derived: sum of 3 quarters · filed 2021-08-12
-$61.45M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$1.58M
10-Q · filed 2021-05-12
-$61.45M
derived: sum of 2 quarters · filed 2021-05-12
-$61.45M
derived: sum of 3 quarters · filed 2021-05-12
-$61.49M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31-$59.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
-$59.87M
derived: sum of 2 quarters · filed 2021-03-16
-$59.91M
derived: sum of 3 quarters · filed 2021-03-16
-$60.55M
10-K · filed 2021-03-16
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$39.00K
derived: sum of 2 quarters · filed 2020-11-06
-$681.00K
10-Q · filed 2020-11-06
-$619.00K
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30-$39.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
-$681.00K
10-Q · filed 2020-08-07
-$619.00K
derived: sum of 3 quarters · filed 2020-08-07
$1.63M
derived: sum of 4 quarters · filed 2020-08-07
2019-03-31-$642.00K
10-Q · filed 2020-05-08
-$580.00K
derived: sum of 2 quarters · filed 2020-05-08
$1.67M
derived: sum of 3 quarters · filed 2020-05-08
$10.65M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31$62.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$2.31M
derived: sum of 2 quarters · filed 2020-02-28
$11.29M
derived: sum of 3 quarters · filed 2020-02-28
$12.80M
10-K · filed 2020-02-28
2018-09-30$2.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$11.23M
derived: sum of 2 quarters · filed 2019-11-07
$12.73M
10-Q · filed 2019-11-07
$67.00M
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30$8.97M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$10.48M
10-Q · filed 2019-08-07
$64.75M
derived: sum of 3 quarters · filed 2020-02-28
$66.28M
derived: sum of 4 quarters · filed 2020-02-28
2018-03-31$1.51M
10-Q · filed 2019-05-07
$55.77M
derived: sum of 2 quarters · filed 2020-02-28
$57.30M
derived: sum of 3 quarters · filed 2020-02-28
2017-12-31$54.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$55.79M
derived: sum of 2 quarters · filed 2020-02-28
$61.52M
10-K · filed 2020-02-28
2017-09-30$1.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$7.25M
10-Q · filed 2018-11-06
2017-06-30$5.73M
10-Q · filed 2018-08-08
2016-12-31$45.93M
10-K · filed 2019-02-27
2011-12-31-$462.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
-$592.00K
derived: sum of 2 quarters · filed 2012-02-28
$1.84M
derived: sum of 3 quarters · filed 2012-02-28
$2.00M
10-K · filed 2012-02-28
2011-09-30-$130.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07
$2.31M
derived: sum of 2 quarters · filed 2011-11-07
$2.46M
10-Q · filed 2011-11-07
-$2.95M
derived: sum of 4 quarters · filed 2012-02-28
2011-06-30$2.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08
$2.59M
10-Q · filed 2011-08-08
-$2.82M
derived: sum of 3 quarters · filed 2012-02-28
-$953.00K
derived: sum of 4 quarters · filed 2012-02-28
2011-03-31$157.00K
10-Q · filed 2011-05-09
-$5.26M
derived: sum of 2 quarters · filed 2012-02-28
-$3.39M
derived: sum of 3 quarters · filed 2012-02-28
-$2.53M
derived: sum of 4 quarters · filed 2012-02-28
2010-12-31-$5.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
-$3.54M
derived: sum of 2 quarters · filed 2012-02-28
-$2.69M
derived: sum of 3 quarters · filed 2012-02-28
$1.19M
10-K · filed 2012-02-28
$1.19M
10-K · filed 2011-03-01
2010-09-30$1.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07
$2.73M
derived: sum of 2 quarters · filed 2011-11-07
$6.61M
10-Q · filed 2011-11-07
$6.61M
10-Q · filed 2010-11-09
$1.38M
derived: sum of 4 quarters · filed 2012-02-28
2010-06-30$860.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08
$4.74M
10-Q · filed 2011-08-08
$4.74M
10-Q · filed 2010-08-09
-$488.77K
derived: sum of 3 quarters · filed 2012-02-28
-$578.42K
derived: sum of 4 quarters · filed 2012-02-28
2010-03-31$3.88M
10-Q · filed 2011-05-09
-$1.35M
derived: sum of 2 quarters · filed 2012-02-28
-$1.44M
derived: sum of 3 quarters · filed 2012-02-28
2009-12-31-$5.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
-$5.31M
derived: sum of 2 quarters · filed 2012-02-28
-$4.53M
10-K · filed 2012-02-28
-$4.53M
10-K · filed 2011-03-01
2009-09-30-$89.65K
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-09
$696.77K
10-Q · filed 2010-11-09
2009-06-30$786.42K
10-Q · filed 2010-08-09
2008-12-31$203.25M
10-K · filed 2011-03-01